Ensysce Biosciences (ENSC) Stock Statistics & Valuation Metrics

Ensysce Biosciences has a market cap or net worth of $4.82M. The enterprise value is $3.69B.

Ensysce Biosciences has 2,370,698 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ensysce Biosciences’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -182.30%.

The current PE Ratio of Ensysce Biosciences is -1.78. Ensysce Biosciences’s PEG ratio is -11.54.

In the last 12 months, Ensysce Biosciences had revenue of 5.21M and earned -7.99M in profits. Earnings per share was -4.57.

In the last 12 months, operating cash flow was -5.80M and capital expenditures 0.00, giving a free cash flow of -5.80M billion.

Ensysce Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Ensysce Biosciences upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.

Ensysce Biosciences as a current ratio of 2.42, with Debt / Equity ratio of 0.30%

In the past 12 months, Ensysce Biosciences has paid 0.00 in taxes.

Ensysce Biosciences EV to EBITDA ratio is -1.64, with an EV/FCF ratio of >-0.01.

Ensysce Biosciences has $3.05M in cash and marketable securities with $257.38K in debt, giving a net cash position of -$2.80M billion.

Gross margin is -88.70%, with operating margin of -129.18%, and net profit margin of -153.30%.

The average price target for Ensysce Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―